Invivyd, Inc. (IVVD)
0.4479
0.00 (0.00%)
USD |
NASDAQ |
Nov 20, 09:49
Invivyd Cash from Investing (Quarterly) : -0.585M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.585M |
| June 30, 2026 | -0.51M |
| March 31, 2026 | -0.726M |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | -0.011M |
| March 31, 2025 | -0.144M |
| December 31, 2024 | 0.005M |
| September 30, 2024 | -0.005M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | -0.14M |
| December 31, 2023 | 77.92M |
| Date | Value |
|---|---|
| September 30, 2023 | 95.14M |
| June 30, 2023 | 32.60M |
| March 31, 2023 | 75.04M |
| December 31, 2022 | -138.81M |
| September 30, 2022 | -140.84M |
| June 30, 2022 | -0.017M |
| March 31, 2022 | 49.00M |
| December 31, 2021 | 137.92M |
| September 30, 2021 | -188.63M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | -5.147M |
| Armata Pharmaceuticals, Inc. | -0.091M |
| Voyager Therapeutics, Inc. | 29.27M |
| Black Diamond Therapeutics, Inc. | 4.218M |
| Elicio Therapeutics, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -32.11M |
| Cash from Financing (Quarterly) | 0.028M |
| Free Cash Flow | -134.11M |
| Free Cash Flow Per Share (Quarterly) | -0.1014 |
| Free Cash Flow to Equity (Quarterly) | -32.56M |
| Free Cash Flow to Firm (Quarterly) | -32.70M |
| Free Cash Flow Yield | -101.3% |